Literature DB >> 518621

Differential binding of antiestrogens by rat uterine and chick oviduct cytosol.

R L Sutherland, M S Foo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 518621     DOI： 10.1016/0006-291x(79)90601-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  9 in total

1.  Microsomal binding sites for antioestrogens in rat liver. Properties and detergent solubilization.

Authors:  C K Watts; R L Sutherland
Journal:  Biochem J       Date:  1986-06-15       Impact factor: 3.857

2.  Solubilization of a tamoxifen-binding protein. Assessment of its molecular mass.

Authors:  A Fargin; J C Faye; M le Maire; F Bayard; M Potier; G Beauregard
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

3.  Tamoxifen binding sites in human mammary cancers.

Authors:  N Fujino; M Kimura; K Sakamoto; N Shigaki; J Yamashita; M Akagi
Journal:  Jpn J Surg       Date:  1986-09

4.  Physicochemical and genetic evidence for specific antiestrogen binding sites.

Authors:  J C Faye; S Jozan; G Redeuilh; E E Baulieu; F Bayard
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

5.  A study on the correlation between estrogen receptor, progesterone receptor and tamoxifen binding sites in human breast cancer tissues.

Authors:  Y Imanaka; S Tsuboi; N Kohno; Y Saitoh
Journal:  Jpn J Surg       Date:  1987-11

6.  Antiestrogen action in breast cancer cells: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites.

Authors:  B S Katzenellenbogen; M A Miller; A Mullick; Y Y Sheen
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

7.  Oestrogen and progesterone receptors in chick oviduct chromatin after administration of oestradiol, progesterone or anti-oestrogen.

Authors:  M C Lebeau; N Massol; E E Baulieu
Journal:  Biochem J       Date:  1982-06-15       Impact factor: 3.857

8.  Synergistic interaction between cisplatin and tamoxifen delays the emergence of cisplatin resistance in head and neck cancer cell lines.

Authors:  B Nakata; K D Albright; R M Barton; S B Howell; G Los
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

9.  Binding sites of droloxifene in the cytosol of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor cells.

Authors:  I Kawamura; E Lacey; Y Tanaka; F Nishigaki; T Manda; K Shimomura
Journal:  Jpn J Cancer Res       Date:  1994-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.